Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Cheng ZhangMengqi ZhangSai GeWenwen HuangXiaoting LinJing GaoJifang GongLin ShenPublished in: Cancer medicine (2019)
Our work demonstrated that low-m6A signatures predicted adverse clinicopathological features of GC, while the reduction of RNA m6A methylation activated oncogenic Wnt/PI3K-Akt signaling and promoted malignant phenotypes of GC cells.